| scholarly article | Q13442814 |
| P50 | author | Francisco Miguel Sanchez Margallo | Q57516151 |
| Veronica Crisostomo | Q73077202 | ||
| Virginia Blanco-Blazquez | Q92447149 | ||
| P2093 | author name string | Antonio Bernad | |
| Olivier Gheysens | |||
| Javier G Casado | |||
| Stefan Janssens | |||
| Belén Sanchez | |||
| Susana Aguilar | |||
| José Luis Abad | |||
| Itziar Palacios | |||
| Claudia Baez | |||
| Guadalupe Gómez-Mauricio | |||
| José Luis Torán | |||
| Luis Rodriguez-Borlado | |||
| Rebeca Blazquez | |||
| Rosalba Rosado | |||
| Virginia Alvarez | |||
| P2860 | cites work | Intrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysis | Q27310275 |
| Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy | Q27322954 | ||
| A New Method to Stabilize C-Kit Expression in Reparative Cardiac Mesenchymal Cells | Q27330396 | ||
| Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery | Q28073078 | ||
| Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model | Q28550109 | ||
| Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
| Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction | Q30570123 | ||
| Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells | Q30596875 | ||
| Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury | Q30841694 | ||
| Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data | Q30896351 | ||
| Pathophysiology Underlying the Bimodal Edema Phenomenon After Myocardial Ischemia/Reperfusion | Q30987222 | ||
| Empowering adult stem cells for myocardial regeneration | Q34239856 | ||
| Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model. | Q34401933 | ||
| Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair | Q34410262 | ||
| Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index | Q34992842 | ||
| Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. | Q35050037 | ||
| Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells | Q35666637 | ||
| Delayed administration of allogeneic cardiac stem cell therapy for acute myocardial infarction could ameliorate adverse remodeling: experimental study in swine. | Q35690093 | ||
| Glutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation | Q35875613 | ||
| Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction | Q35883152 | ||
| Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance | Q36252910 | ||
| Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection | Q36317528 | ||
| Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial | Q36603453 | ||
| Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint | Q37090723 | ||
| Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy | Q37253597 | ||
| Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies | Q38245936 | ||
| Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter D | Q38376515 | ||
| Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial | Q38420807 | ||
| Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage | Q38688841 | ||
| Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical Studies. | Q38738174 | ||
| Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. | Q38874116 | ||
| Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy | Q38997197 | ||
| ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design | Q39471106 | ||
| Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy | Q39864941 | ||
| Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction | Q41888608 | ||
| CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretome. | Q42286197 | ||
| Expression of concern: the SCIPIO trial | Q42354504 | ||
| Allogeneic cell therapy: a new paradigm in therapeutics. | Q42545530 | ||
| Podocalyxin-like protein 1 is a relevant marker for human c-kit(pos) cardiac stem cells. | Q45230770 | ||
| Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine | Q46130031 | ||
| Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells | Q47108276 | ||
| Intracoronary injection of large stem cells: size matters | Q47388670 | ||
| Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study). | Q47551265 | ||
| Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. | Q47574001 | ||
| Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association | Q49546493 | ||
| Cardioprotection by cardiac progenitor cell-secreted exosomes:Role of pregnancy-associated plasma protein-A. | Q52727870 | ||
| Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence. | Q53154015 | ||
| Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1. | Q54465293 | ||
| Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. | Q55261465 | ||
| Global position paper on cardiovascular regenerative medicine | Q56985687 | ||
| Myoblast transplantation for heart failure | Q58109127 | ||
| Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit Cardiac Stem Cells As Regenerative Therapy for Heart Failure) | Q62632808 | ||
| Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization | Q64090961 | ||
| Preclinical Studies of Stem Cell Therapy for Heart Disease | Q88219970 | ||
| Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction | Q89157543 | ||
| Intramyocardial stem cell injection: go(ne) with the flow | Q89196320 | ||
| Meta-Analysis of Cell Therapy Studies in Heart Failure and Acute Myocardial Infarction | Q89433773 | ||
| Regenerating the field of cardiovascular cell therapy | Q91691962 | ||
| P433 | issue | 1 | |
| P921 | main subject | acute myocardial infarction | Q18558122 |
| P304 | page(s) | 152 | |
| P577 | publication date | 2019-05-31 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells | |
| P478 | volume | 10 |
| Q94452130 | Microencapsulated Insulin-Like Growth Factor-1 therapy improves cardiac function and reduces fibrosis in a porcine acute myocardial infarction model | cites work | P2860 |
Search more.